Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Quantitative appraisal of treatment options for IgA nephropathy Ballardie FWJ Am Soc Nephrol 2007[Nov]; 18 (11): 2806-9IgA nephropathy has an impact on renal health care costs worldwide. The paucity of good clinical trials highlights the uncertainty in determining best treatment and for how long. Ongoing debate still raises questions on why opinions vary but may suggest that current data are not fully understood. The scale of benefit of immunosuppressive drugs in suppressing clinical nephritis or improving outcome is unmatched by use of renin-angiotensin inhibitors alone. By minimizing the use of immunosuppressive drugs, higher risk patients may hazard more ESRD. This review addresses how disparate views have formed, quantifying existing data, to give balance to recommendations.|Angiotensin II Type 1 Receptor Blockers/*therapeutic use[MESH]|Angiotensin-Converting Enzyme Inhibitors/*therapeutic use[MESH]|Glomerulonephritis, IGA/complications/*drug therapy[MESH]|Humans[MESH]|Immunosuppressive Agents/*therapeutic use[MESH]|Kidney Failure, Chronic/etiology/*prevention & control[MESH]|Treatment Outcome[MESH] |
